|
|
|
Volumn 5, Issue 5, 1999, Pages
|
|
Current status of acute intravenous therapy for chronic heart failure exacerbations
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATRIAL NATRIURETIC FACTOR;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BRAIN NATRIURETIC PEPTIDE;
BUMETANIDE;
CALCIUM SENSITIZER;
CONIVAPTAN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DOBUTAMINE;
DOPAMINE;
ENALAPRILAT;
FUROSEMIDE;
GLYCERYL TRINITRATE;
INOTROPIC AGENT;
LEVOSIMENDAN;
MILRINONE;
NATRIURETIC FACTOR;
NITROPRUSSIDE SODIUM;
PHOSPHODIESTERASE INHIBITOR;
PROSTACYCLIN;
TOLVAPTAN;
UNCLASSIFIED DRUG;
VASODILATOR AGENT;
VASOPRESSIN RECEPTOR ANTAGONIST;
CLINICAL TRIAL;
DRUG MECHANISM;
HEART FAILURE;
HEART HEMODYNAMICS;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
HYPOTENSION;
INOTROPISM;
INTRAVENOUS DRUG ADMINISTRATION;
MORTALITY;
REVIEW;
TACHYCARDIA;
|
|
EID: 0033429839
PISSN: 10797998
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (50)
|
